We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$463M
AUM Growth
+$88.4M
Cap. Flow
+$76.3M
Cap. Flow %
16.48%
Top 10 Hldgs %
15.82%
Holding
310
New
106
Increased
69
Reduced
87
Closed
41

Top Buys

Rank Stock Value
1
PFPT
Proofpoint, Inc.
PFPT
+$5.74M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$5.51M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.03M
4
IMPV
Imperva, Inc.
IMPV
+$4.56M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$2.3M

Top Sells

Rank Stock Value
1
TEN
Tenneco Inc. Class A Voting Common Stock
TEN
+$4.9M
2
TSCO icon
Tractor Supply
TSCO
+$4.44M
3
LPNT
LifePoint Health, Inc.
LPNT
+$3.96M
4
WCC
WESCO International
WCC
+$3.55M
5
IDTI
Integrated Device Technology I
IDTI
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Technology 14.58%
3 Industrials 10.71%
4 Consumer Staples 7.92%
5 Materials 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTR icon
76
Ventas
VTR
$48.5B
$1.53M 0.33%
25,551
+110
+0.4% +$6.95K
OGE icon
77
OGE Energy
OGE
$10.3B
$1.45M 0.31%
43,951
+15
+0% +$530
MWA icon
78
Mueller Water Products
MWA
$3.92B
$1.35M 0.29%
108,108
+82,593
+324% +$1.02M
SPY icon
79
State Street SPDR S&P 500 ETF Trust
SPY
$780B
$1.32M 0.28%
4,943
-289
-6% -$75.2K
EGRX
80
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.28M 0.28%
24,000
– –
MON
81
DELISTED
Monsanto Co
MON
$1.27M 0.27%
10,889
-6,327
-37% -$753K
SCL icon
82
Stepan Co
SCL
$1.32B
$1.24M 0.27%
15,705
-351
-2% -$28.8K
LGTY
83
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$1.21M 0.26%
104,126
-1,077
-1% -$13K
SLP icon
84
Simulations Plus
SLP
$371M
$1.19M 0.26%
74,101
-3,263
-4% -$53.6K
BPL
85
DELISTED
Buckeye Partners, L.P.
BPL
$1.18M 0.26%
23,855
-1,125
-5% -$57.1K
SANM icon
86
Sanmina
SANM
$11.4B
$1.15M 0.25%
34,806
-1,822
-5% -$63.6K
NEWR
87
DELISTED
New Relic, Inc.
NEWR
$1.14M 0.25%
+19,720
New +$1.07M
MRK icon
88
Merck
MRK
$324B
$1.12M 0.24%
20,839
+11,588
+125% +$642K
JBTM
89
JBT Marel
JBTM
$7.11B
$1.11M 0.24%
10,052
-8,143
-45% -$889K
UNH icon
90
UnitedHealth
UNH
$382B
$1.1M 0.24%
5,012
-94
-2% -$19.9K
JNJ icon
91
Johnson & Johnson
JNJ
$633B
$1.09M 0.24%
7,800
-203
-3% -$28.3K
ADM icon
92
Archer Daniels Midland
ADM
$41.6B
$1.09M 0.23%
27,135
+2,222
+9% +$91.4K
AAPL icon
93
Apple
AAPL
$4.88T
$1.08M 0.23%
25,584
-316
-1% -$13.2K
WTRG icon
94
Essential Utilities
WTRG
$11.2B
$1.06M 0.23%
27,013
-1,023
-4% -$37.3K
NVTA
95
DELISTED
Invitae Corporation
NVTA
$1.05M 0.23%
+116,124
New +$1.04M
NEE icon
96
NextEra Energy
NEE
$186B
$1.05M 0.23%
26,852
+404
+2% +$15.6K
CBPX
97
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$1.04M 0.22%
36,985
-1,041
-3% -$28.2K
IJH icon
98
iShares Core S&P Mid-Cap ETF
IJH
$123B
$1.03M 0.22%
27,120
-720
-3% -$26.6K
ACGN
99
DELISTED
Aceragen Inc
ACGN
$1.02M 0.22%
+3,561
New +$1.02M
ZEN
100
DELISTED
ZENDESK INC
ZEN
$1M 0.22%
+29,625
New +$970K
2 3
4
5 6

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q4 2017 Portfolio in Review

As of Q4 2017, Stanley-Laman Group held 310 positions worth $463M, up 24% from $375M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group deployed $76.3M of net new capital in Q4 2017, opening 106 new positions and adding to 69 existing holdings. Its largest new stake was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was JBT Marel, an estimated $889K trimmed.

  • Stanley-Laman Group's largest Q4 2017 buy was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.
  • Stanley-Laman Group added most to Proofpoint, Inc. in Q4 2017, an estimated $5.74M increase.
  • Stanley-Laman Group's biggest Q4 2017 reduction was JBT Marel, cutting an estimated $889K.
  • Stanley-Laman Group fully exited Tenneco Inc. Class A Voting Common Stock in Q4 2017, selling an estimated $4.9M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $463M portfolio in Q4 2017.
  • Stanley-Laman Group opened 106 new positions and closed 41 in Q4 2017.
  • Stanley-Laman Group's portfolio value rose 24% quarter-over-quarter to $463M.

Based on Stanley-Laman Group's 13F filing for Q4 2017, filed 9 Feb 2018.